Endo International plc (ENDP) belongs to the “Healthcare” sector with an industry focus on “Drug Manufacturers – Other”, with Mr. Paul V. Campanelli as Chief Exec. Officer, Pres and Director.
The company has been one of the biggest innovators in “Drug Manufacturers – Other” employing approximately 4894 full time employees.
- The stock subtracted in the prior trading session by -5.43%, closing at the stock price of $11.84.
- Currently, the market capitalization of Endo International plc (ENDP) is 2.64 Billion.
- ENDP has a 1-year high price of $ 24.93 and 1-year low price of $9.70.
- The number of shares currently held by investors is 223.11 Million.
- The number of shares traded in the last trading session was 9.9 Million.
Currently the shares of Endo International plc (ENDP) has a trading volume of 9.9 Million shares, with an average trading volume of 9980 shares – with shares dropping to a 52 week low of $9.70, and the company’s shares hitting a 52 week high of $ 24.93.
Looking at the current price of the stock and the 52 week high and low, it suggests that the stock is likely to go Up in the future.
Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for Endo International plc the EPS stands at 1.23 for the previous quarter, while the analysts predicted the EPS of the stock to be 1.1, suggesting the stock exceeded the analysts’ expectations.
Another critical number in evaluating a stock is P/E or the price to earnings ratio.
The TTM operating margin is -84.4%. The return on invested capital at -25.3%, which is good, compared to its peers.
The Free Cash Flow or FCF margin is 4.65%, which means that the business has healthy reserve funds for contingencies that may arise.
Stock is currently moving with a negative distance from the 200 day simple moving average of approximately -24.9%, and has a poor year to date (YTD) performance of -28.11% which means the stock is constantly subtracting to its value from the previous fiscal year end price.
The stock diminished about -1.5% in the past 5 years, this negative value indicates that the stock constantly going down in previous years as well.
The target price for Endo International plc (ENDP) is $15.75/share according to the consensus of analysts working on the stock, with an expected EPS of $0.73/share for the current quarter.
The company’s expected revenue in the current quarter to be 835.14 Million, seeing a projected current quarter growth of -15.1%, and per annum growth estimates over the next 5 year period of around -6.49%.